Advertisement
Canada markets close in 5 hours 36 minutes
  • S&P/TSX

    21,723.92
    -149.80 (-0.68%)
     
  • S&P 500

    5,010.37
    -61.26 (-1.21%)
     
  • DOW

    37,821.48
    -639.44 (-1.66%)
     
  • CAD/USD

    0.7295
    -0.0002 (-0.03%)
     
  • CRUDE OIL

    82.38
    -0.43 (-0.52%)
     
  • Bitcoin CAD

    87,345.02
    -2,884.74 (-3.20%)
     
  • CMC Crypto 200

    1,374.94
    -7.63 (-0.55%)
     
  • GOLD FUTURES

    2,332.90
    -5.50 (-0.24%)
     
  • RUSSELL 2000

    1,961.98
    -33.44 (-1.68%)
     
  • 10-Yr Bond

    4.7290
    +0.0770 (+1.66%)
     
  • NASDAQ

    15,494.32
    -218.43 (-1.39%)
     
  • VOLATILITY

    17.36
    +1.39 (+8.70%)
     
  • FTSE

    8,051.39
    +11.01 (+0.14%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6806
    -0.0013 (-0.19%)
     

Tilray’s Q2 2018 Results and Its Strategic Focus

Tilray’s Q2 2018 Results and Its Strategic Focus

Tilray’s (TLRY) average selling prices and sales volume improved year-over-year in the second quarter. Looking at the sales volume, there was an overall increase, which indicates an increased uptake in the demand for Tilray’s products. The growth in average selling prices was driven by “higher potency products and extract sales” according to the company.